A new report commissioned by the Association of the British Pharmaceutical Industry (ABPI) has found that hospitals engaging ...

HALIX, a Dutch contract development and manufacturing organisation (CDMO) specialising in complex therapeutic antibodies and ...

During pilot programmes, Concentriq Embeddings demonstrated its ability to significantly accelerate AI development. In one ...

In the third, final, and by most reckonings most inconsequential, national debate of the US presidential election, vice ...

Starting January 1, 2025, most Blue Shield commercial members using Fresenius Kabi's adalimumab-aacf (a Humira biosimilar) ...

The lawsuit, originally filed by the Roofers Local No. 149 Pension Fund in 2023, alleges that Amgen misled shareholders by ...

Seven new clinical trial grants were awarded under the Orphan Product Grants Program during the fiscal year (FY) 2024, ...

A functional point of contact (FPOC) is a dedicated liaison in each functional area responsible for evaluating and ...

The month-long standoff between the US Health Resources and Services Administration (HRSA) and Johnson & Johnson came to an ...

Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the ...

UCB taps new UK head. Belgium-based global biopharmaceutical company UCB welcomed Nico Reynders as its new general manager ...

Chiesi’s strategy aligns with EU priorities on innovation, security, and private R&D investment: the decision to establish a ...